Get the latest Science News and Discoveries

Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

Get the Android app

Or read this on New York Times

Read more on:

Photo of panel tells f.d.a

panel tells f.d.a

Photo of patients


Related news:

News photo

How a Lucrative Surgery Took Off Online and Disfigured Patients

News photo

Doctors Do Racist Things to Patients. Here Are Seven Ways They Can Stop

News photo

People with depression can't access potentially life-changing treatment with ketamine because current systems prioritize profits, not patients & payers. New study reveals the systemic barriers that prevent the utilization of existing, low-cost drugs.